Protalix Biotherapeutics, Inc.
(NYSE Amex Equities : PLX)

( )
PLX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Services » Servicestothe Health Industry
symbolcompany%chnglast%shortavg$volume
LHLaboratory Corp. of America Holdings 0.04%276.192.4%$231.03m
IQVIQVIA Holdings, Inc. 0.04%247.440.0%$188.63m
DGXQuest Diagnostics, Inc. -0.02%142.274.7%$151.38m
AMEHApollo Medical Holdings, Inc. 0.00%60.350.0%$22.39m
NOTVInotiv, Inc. 0.00%32.860.0%$5.77m
BASIBioanalytical Systems, Inc. 0.00%32.860.2%$3.39m
NRCNational Research Corp. 0.00%38.210.0%$1.33m
PLXProtalix Biotherapeutics, Inc. -1.14%0.8518.5%$0.46m
QIPTQuipt Home Medical Corp. -0.18%5.650.0%$0.24m
PMDPsychemedics Corp. 0.00%7.170.7%$0.14m

Company Profile

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.